Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells

Abstract HIV-1 infection elevates the risk of developing various cancers, including T-cell lymphoma. Whether HIV-1-encoded proteins directly contribute to oncogenesis remains unknown. We observe that approximately 1–5% of CD4+ T cells from the blood of people living with HIV-1 exhibit over-duplicate...

Full description

Saved in:
Bibliographic Details
Main Authors: Jung-Eun Park, Tae-Sung Kim, Yan Zeng, Melissa Mikolaj, Jong Il Ahn, Muhammad S. Alam, Christina M. Monnie, Victoria Shi, Ming Zhou, Tae-Wook Chun, Frank Maldarelli, Kedar Narayan, Jinwoo Ahn, Jonathan D. Ashwell, Klaus Strebel, Kyung S. Lee
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-46306-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571536516579328
author Jung-Eun Park
Tae-Sung Kim
Yan Zeng
Melissa Mikolaj
Jong Il Ahn
Muhammad S. Alam
Christina M. Monnie
Victoria Shi
Ming Zhou
Tae-Wook Chun
Frank Maldarelli
Kedar Narayan
Jinwoo Ahn
Jonathan D. Ashwell
Klaus Strebel
Kyung S. Lee
author_facet Jung-Eun Park
Tae-Sung Kim
Yan Zeng
Melissa Mikolaj
Jong Il Ahn
Muhammad S. Alam
Christina M. Monnie
Victoria Shi
Ming Zhou
Tae-Wook Chun
Frank Maldarelli
Kedar Narayan
Jinwoo Ahn
Jonathan D. Ashwell
Klaus Strebel
Kyung S. Lee
author_sort Jung-Eun Park
collection DOAJ
description Abstract HIV-1 infection elevates the risk of developing various cancers, including T-cell lymphoma. Whether HIV-1-encoded proteins directly contribute to oncogenesis remains unknown. We observe that approximately 1–5% of CD4+ T cells from the blood of people living with HIV-1 exhibit over-duplicated centrioles, suggesting that centrosome amplification underlies the development of HIV-1-associated cancers by driving aneuploidy. Through affinity purification, biochemical, and cellular analyses, we discover that Vpr, an accessory protein of HIV-1, hijacks the centriole duplication machinery and induces centrosome amplification and aneuploidy. Mechanistically, Vpr forms a cooperative ternary complex with an E3 ligase subunit, VprBP, and polo-like kinase 4 (Plk4). Unexpectedly, however, the complex enhances Plk4’s functionality by promoting its relocalization to the procentriole assembly and induces centrosome amplification. Loss of either Vpr’s C-terminal 17 residues or VprBP acidic region, the two elements required for binding to Plk4 cryptic polo-box, abrogates Vpr’s capacity to induce these events. Furthermore, HIV-1 WT, but not its Vpr mutant, induces multiple centrosomes and aneuploidy in human primary CD4+ T cells. We propose that the Vpr•VprBP•Plk4 complex serves as a molecular link that connects HIV-1 infection to oncogenesis and that inhibiting the Vpr C-terminal motif may reduce the occurrence of HIV-1-associated cancers.
format Article
id doaj-art-a62a5df966d346acae50282c12b35957
institution Kabale University
issn 2041-1723
language English
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-a62a5df966d346acae50282c12b359572025-02-02T12:31:01ZengNature PortfolioNature Communications2041-17232024-03-0115111810.1038/s41467-024-46306-8Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cellsJung-Eun Park0Tae-Sung Kim1Yan Zeng2Melissa Mikolaj3Jong Il Ahn4Muhammad S. Alam5Christina M. Monnie6Victoria Shi7Ming Zhou8Tae-Wook Chun9Frank Maldarelli10Kedar Narayan11Jinwoo Ahn12Jonathan D. Ashwell13Klaus Strebel14Kyung S. Lee15Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of HealthCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of HealthCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of HealthCenter for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of HealthCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of HealthLaboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of HealthDepartment of Structural Biology, University of Pittsburgh School of MedicineLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of HealthProtein Characterization Laboratory, Frederick National Laboratory for Cancer ResearchLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of HealthHIV Dynamics and Replication Program, National Cancer Institute, National Institutes of HealthCenter for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of HealthDepartment of Structural Biology, University of Pittsburgh School of MedicineLaboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of HealthLaboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of HealthCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of HealthAbstract HIV-1 infection elevates the risk of developing various cancers, including T-cell lymphoma. Whether HIV-1-encoded proteins directly contribute to oncogenesis remains unknown. We observe that approximately 1–5% of CD4+ T cells from the blood of people living with HIV-1 exhibit over-duplicated centrioles, suggesting that centrosome amplification underlies the development of HIV-1-associated cancers by driving aneuploidy. Through affinity purification, biochemical, and cellular analyses, we discover that Vpr, an accessory protein of HIV-1, hijacks the centriole duplication machinery and induces centrosome amplification and aneuploidy. Mechanistically, Vpr forms a cooperative ternary complex with an E3 ligase subunit, VprBP, and polo-like kinase 4 (Plk4). Unexpectedly, however, the complex enhances Plk4’s functionality by promoting its relocalization to the procentriole assembly and induces centrosome amplification. Loss of either Vpr’s C-terminal 17 residues or VprBP acidic region, the two elements required for binding to Plk4 cryptic polo-box, abrogates Vpr’s capacity to induce these events. Furthermore, HIV-1 WT, but not its Vpr mutant, induces multiple centrosomes and aneuploidy in human primary CD4+ T cells. We propose that the Vpr•VprBP•Plk4 complex serves as a molecular link that connects HIV-1 infection to oncogenesis and that inhibiting the Vpr C-terminal motif may reduce the occurrence of HIV-1-associated cancers.https://doi.org/10.1038/s41467-024-46306-8
spellingShingle Jung-Eun Park
Tae-Sung Kim
Yan Zeng
Melissa Mikolaj
Jong Il Ahn
Muhammad S. Alam
Christina M. Monnie
Victoria Shi
Ming Zhou
Tae-Wook Chun
Frank Maldarelli
Kedar Narayan
Jinwoo Ahn
Jonathan D. Ashwell
Klaus Strebel
Kyung S. Lee
Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
Nature Communications
title Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
title_full Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
title_fullStr Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
title_full_unstemmed Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
title_short Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4+ T cells
title_sort centrosome amplification and aneuploidy driven by the hiv 1 induced vpr•vprbp•plk4 complex in cd4 t cells
url https://doi.org/10.1038/s41467-024-46306-8
work_keys_str_mv AT jungeunpark centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT taesungkim centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT yanzeng centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT melissamikolaj centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT jongilahn centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT muhammadsalam centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT christinammonnie centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT victoriashi centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT mingzhou centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT taewookchun centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT frankmaldarelli centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT kedarnarayan centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT jinwooahn centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT jonathandashwell centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT klausstrebel centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells
AT kyungslee centrosomeamplificationandaneuploidydrivenbythehiv1inducedvprvprbpplk4complexincd4tcells